NuvoAir AB

Boston, MA, USA, with an office in Stockholm, Sweden. All Sweden companies → — Founded 2015

Clinical AI Platform Medical Device / Hardware Wearables / RPM

Allergy & Immunology Pulmonology

Lab & Diagnostics Telehealth & Virtual Care Wearables & Remote Monitoring (RPM)

Series A

Claim this company

About NuvoAir AB

NuvoAir AB is a digital health company that provides a comprehensive platform for personalized heart and lung care, primarily focusing on chronic respiratory conditions such as asthma, COPD, cystic fibrosis, and neuromuscular disorders. The company integrates proprietary hardware (like Bluetooth-enabled spirometers and inhaler sensors), software (including an AI-backed cough detection app), and data analytics to offer continuous, proactive virtual care. This platform enables patients to perform lung function tests and monitor their health from home, sharing real-time data with their healthcare providers. NuvoAir’s approach aims to empower both patients and clinicians with data-driven insights to improve diagnosis, treatment, and management of respiratory conditions.

For physicians, NuvoAir’s platform offers clinical decision support tools and a means to streamline care and amplify outcomes. The system provides real-time data tracking and virtual consultations, allowing for informed decisions and personalized care plans. Pilot studies have shown improved patient outcomes, including a significant reduction in urgent consultations and hospitalizations, and a high user retention rate. NuvoAir operates on a subscription-based model and partners with healthcare providers, health plans, and researchers, with its platform available across the U.S. The company also leverages AI to analyze vast amounts of data, predict, and optimize care pathways, enhancing the personalization of patient journeys while maintaining a human-led care approach.

Focus Areas

Respiratory care cardiopulmonary care chronic disease management remote patient monitoring digital therapeutics decentralized clinical trials asthma COPD cystic fibrosis chronic heart failure

Business Intelligence

Technology

Cloud-based analytics dashboard, Bluetooth-enabled spirometers, inhaler sensors, patient mobile app, clinician portal, AI-driven insights

What Physicians Need to Know

Specialization in Respiratory Conditions

NuvoAir AB specializes in managing a wide range of respiratory conditions, including COPD, asthma, cystic fibrosis, emphysema, and chronic bronchitis. They offer personalized treatment plans and remote monitoring to alleviate symptoms and improve respiratory function.

Focus on Heart Conditions

NuvoAir provides virtual-first specialty care for individuals with heart conditions such as heart failure, hypertension, high blood pressure, stroke, Afib, and arrhythmia, aiming for continuous and proactive management.

Management of Sleep Conditions

The company addresses sleep disorders like obstructive sleep apnea (OSA) through comprehensive sleep assessments and therapeutic interventions to improve sleep quality.

Remote Monitoring & Digital Therapeutics

NuvoAir's platform blends connected devices, such as Bluetooth-enabled spirometers and inhaler sensors, with a patient mobile app for remote monitoring of lung function and proactive care.

Decentralized Clinical Trials

NuvoAir offers a decentralized clinical trial solution that has been used in over 30 studies globally, enabling participants to collect respiratory endpoints from home and reducing the burden of clinic visits.

Value-Based Care Model

NuvoAir operates on a value-based specialty care model, providing continuous, proactive virtual care for heart and lung conditions, which aims to improve patient outcomes and reduce healthcare costs.

AI-Driven Patient Management

While not explicitly detailed in the provided search results, NuvoAir's focus on digital health and advanced technology suggests the integration of AI for patient management and personalized care plans.

Physician Tip

NuvoAir offers physicians a comprehensive platform for managing chronic cardiopulmonary conditions through a virtual-first, value-based care model. Their integrated system, combining remote spirometry, inhaler sensing, and a patient app, enables continuous monitoring and proactive intervention, potentially reducing urgent hospital visits and improving patient quality of life. The platform supports personalized treatment plans and facilitates decentralized clinical trials, offering a patient-centric approach to data collection and study participation. NuvoAir's approach can enhance clinical capabilities and streamline healthcare delivery by providing access to a multidisciplinary care team and supporting both virtual and in-person consultations.

NuvoAir's platform is designed to integrate connected devices like Bluetooth-enabled spirometers and inhaler sensors. While specific EMR/EHR integrations are not detailed, their focus on providing resources for healthcare providers, including integration tips and data interpretation, suggests a commitment to seamless integration within existing clinical workflows.

Products by NuvoAir AB

No products listed for this company yet. Know of one? Suggest it →

What the Web Says

NuvoAir AB is a company focused on personalized heart and lung care through remote monitoring and tailored plans. Their main product is a handheld spirometer that connects to a smartphone app, designed for patients with respiratory conditions like Asthma, COPD, and Cystic Fibrosis. While the company is praised by some employees for its empathetic team and growth opportunities, its product, the NuvoAir Home app and spirometer, receives mixed to negative reviews due to frequent bugs and connectivity issues.

Overall: Mixed

Strengths

Empathetic and caring team.
Open to new ideas.
Good company for learning and growth.
Good pay for some roles.
Product helps patients engage in telemedicine and reduces in-person consultations.
Spirometer is accurate and maintenance-free.

Limitations

High turnover rate for health coaches.
Product (app and spirometer) is buggy and crashes frequently.
App often fails to save or send results.
App can be unusable if the website is down.
Concerns about the company's approach to health coaching for severely ill patients.
Work-life balance, compensation, job security, advancement, management, and culture received low ratings from some employees.

Based on reviews from: Indeed.com, G2, App Store (Apple), Reddit, Google Play, Cystic Fibrosis News Today

Last updated: 2026-10-21

Videos

News, demos, and interviews about NuvoAir AB.

Loading videos...

Videos load interactively. If none appear, search YouTube for NuvoAir AB →

View all on YouTube

Press & Coverage

NuvoAir

NuvoAir's Air Next Spirometer is FDA-approved for in-home use

NuvoAir Medical announced that its Air Next Spirometer received 510(k) clearance from the FDA for in-home use as a full spirometer, enabling continuous patient monitoring and scaling of clinical operations.

2024-01

Respiratory Therapy

FDA Clears NuvoAir's Air Next Spirometer for Home Use

The FDA granted 510(k) clearance to NuvoAir's Air Next spirometer for in-home use, allowing comprehensive lung function tests at home for continuous monitoring of conditions like COPD and asthma.

2024-02

Medical Device Network

FDA approves NuvoAir's home-use spirometer

NuvoAir received FDA 510(k) clearance for its Air Next spirometer for in-home use, enabling individuals to conduct full lung function tests at home and providing data for continuous monitoring of respiratory conditions.

2024-01

NuvoAir

NuvoAir Medical and Curana Health Forge Partnership to Transform COPD Care

NuvoAir Medical partnered with Curana Health to deploy its portable lung-function testing platform across Curana's long-term care communities to improve COPD identification and management.

2025-07

NuvoAir

NuvoAir and Cary Medical Management announce partnership to bring high-quality cardiopulmonary care to rural North Carolina

NuvoAir Medical partnered with Cary Medical Management to provide in-home and virtual care for patients with complex heart and lung issues in North Carolina.

2024-01

NuvoAir

NuvoAir Partners with Medidata to Advance Digital Respiratory Endpoints in Clinical Trials

NuvoAir partnered with Medidata to integrate its suite of connected devices into the Medidata Sensor Cloud Network, advancing the collection of respiratory endpoints in decentralized and hybrid clinical trials.

2023-10

MobiHealthNews

US FDA clears NuvoAir's connected spirometer device

NuvoAir received its first FDA 510(k) clearance for Air Next, a portable and connected home-use spirometer device designed for patients with asthma, COPD, or cystic fibrosis.

2020-01

Growjo

NuvoAir Raises $12M Series A to Help Treat Chronic Respiratory Illnesses

NuvoAir secured $12 million in Series A funding led by AlbionVC, with participation from KAYA, Amino Collective, and existing shareholders, to expand its chronic disease management and clinical trial platforms.

2021-06

Frequently Asked Questions

What products and services does NuvoAir AB offer for managing respiratory and heart conditions?

NuvoAir AB offers a virtual-first specialty care platform for managing chronic heart and lung conditions such as COPD, asthma, cystic fibrosis, IPF, ALS, muscular dystrophy, and heart failure. Their platform includes connected devices like the Air Next spirometer, pulse oximeter, and activity trackers, an integrated patient app, clinician software, and a multidisciplinary care team for continuous remote monitoring and personalized care plans.

How does NuvoAir AB incorporate AI into its patient management and clinical trial solutions?

NuvoAir utilizes AI-driven forums and algorithms to capture and analyze respiratory data, augment inhalational techniques, and manage medication routines. For clinical trials, they partner with companies like ArtiQ to provide AI-based over-reading of spirometry data, enabling automated quality control and instant feedback on test quality.

What is NuvoAir AB's approach to value-based care and how does it benefit healthcare providers and patients?

NuvoAir AB operates on a value-based care model, aiming to reduce healthcare costs while improving patient outcomes. They partner with health plans, accountable care organizations, and risk-bearing entities, and their model has shown reductions in urgent hospital visits and high patient retention rates.

What kind of support does NuvoAir AB provide for its users and how can they ensure compliance with medical standards?

NuvoAir provides customer support via email and offers a help center with answers, tips, and guides. Their Air Next Spirometer is a CE certified Class IIa Medical Device and has FDA 510k clearance, validated against ATS/ISO standard curves, ensuring compliance with medical device regulations.

What partnerships does NuvoAir AB have, and how do they contribute to the company's stability and offerings?

NuvoAir AB has strategic partnerships with various organizations, including health plans (e.g., Anthem-Emblem, Humana, Cigna, UnitedHealthcare), device vendors, and provider groups like the ALS Association and Cary Medical Management. These collaborations expand their ecosystem across advocacy, clinical delivery, and enable them to offer high-quality cardiopulmonary care to a broader patient population, including those in rural areas.

Does NuvoAir AB offer solutions for sleep conditions, and what is their approach?

Yes, NuvoAir Medical offers a personalized sleep program for sleep conditions like sleep apnea. Their dedicated care team, including Sleep Disorder Specialists and respiratory therapists, helps coordinate sleep studies, CPAP setup, and ongoing management, focusing on a holistic approach that includes sleep hygiene and positional therapy.

What is the company's stability and growth outlook, especially concerning recent developments like the acquisition of its clinical trials business?

NuvoAir has demonstrated measured, resilience-oriented growth, particularly within the virtual-first spirometry-enabled specialty-care niche. While Strados Labs acquired NuvoAir's clinical trials business in March 2026, NuvoAir Medical continues to deepen its commitment to pulmonary patients by providing access to remote and in-person pulmonology specialists and chronic care management.